ICER's launch price and access report: 5 key takeaways and 5 questions we should all be asking
{{output}}
Improving prescription drug affordability and patient access remains a key policy objective in the US health care system, yet not every proposed solution will help us achieve this goal. To contribute to this ongoing policy discussion, the Institute for Clinica... ...
